causal

Wide Therapeutic Window Eases SMA Dosing Risk

SMA therapy had a favorable therapeutic window because the range of the target protein across people is so wide that you can almost not have too much, which reduces the toxicity and undershoot problems that narrow-window drugs suffer.

causalpending

Speaker

Dinakar

Evidence Quote

“there's such a massive range of this protein in the body that's pretty clear that you almost can't have too much.”

Source

Dinakar Singh - A Father’s Call To Action - [Invest Like the Best, EP.428]— Invest Like the Best
Created: 11/12/2026, 3:19:03 AM

Your notes

Loading notes...